Immediate Impact

51 hit
Sub-graph 1 of 23

Citing Papers

Small Cell Lung Cancer
2025 Hit
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Hit
6 intermediate papers

Works of Chiyuki Okuda being referenced

Programmed death-ligand 1 expression and T790M status in EGFR -mutant non-small cell lung cancer
2017
EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer
2015
and 2 more

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Chiyuki Okuda 348 299 107 84 82 33 590
Hiroaki Sakamoto 181 0.5× 173 0.6× 94 0.9× 47 0.6× 70 0.9× 49 556
Anne Rogiers 159 0.5× 291 1.0× 87 0.8× 42 0.5× 44 0.5× 34 514
Claudia Bonardi 197 0.6× 263 0.9× 112 1.0× 65 0.8× 39 0.5× 27 640
A. Katzenwadel 227 0.7× 122 0.4× 133 1.2× 45 0.5× 55 0.7× 22 545
Marlon Garzo Saria 181 0.5× 139 0.5× 237 2.2× 293 3.5× 39 0.5× 35 675
Jean M. Hansen 117 0.3× 144 0.5× 163 1.5× 88 1.0× 114 1.4× 32 647
Claudia De Angelis 138 0.4× 229 0.8× 103 1.0× 88 1.0× 32 0.4× 34 506
Christian Huidobro 253 0.7× 192 0.6× 273 2.6× 108 1.3× 37 0.5× 31 698
D Arsène 255 0.7× 294 1.0× 75 0.7× 29 0.3× 23 0.3× 48 642
Anne Winther‐Larsen 225 0.6× 175 0.6× 114 1.1× 167 2.0× 18 0.2× 39 497

All Works

Loading papers...

Rankless by CCL
2026